Off-Label Use ofAlemtuzumab, Belatacept, and Rapamycin in Kidney Transplantation
Conferences
Krynychka, K; Bhavsar, N; Rogers, U; Jackson, A; Ellis, M; Luo, X; Kirk, A
Published in: AMERICAN JOURNAL OF TRANSPLANTATION
June 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
June 2024
Volume
24
Issue
6
Start / End Page
S492 / S492
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Krynychka, K., Bhavsar, N., Rogers, U., Jackson, A., Ellis, M., Luo, X., & Kirk, A. (2024). Off-Label Use ofAlemtuzumab, Belatacept, and Rapamycin in Kidney Transplantation. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 24, pp. S492–S492).
Krynychka, K., N. Bhavsar, U. Rogers, A. Jackson, M. Ellis, X. Luo, and A. Kirk. “Off-Label Use ofAlemtuzumab, Belatacept, and Rapamycin in Kidney Transplantation.” In AMERICAN JOURNAL OF TRANSPLANTATION, 24:S492–S492, 2024.
Krynychka K, Bhavsar N, Rogers U, Jackson A, Ellis M, Luo X, et al. Off-Label Use ofAlemtuzumab, Belatacept, and Rapamycin in Kidney Transplantation. In: AMERICAN JOURNAL OF TRANSPLANTATION. 2024. p. S492–S492.
Krynychka, K., et al. “Off-Label Use ofAlemtuzumab, Belatacept, and Rapamycin in Kidney Transplantation.” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 24, no. 6, 2024, pp. S492–S492.
Krynychka K, Bhavsar N, Rogers U, Jackson A, Ellis M, Luo X, Kirk A. Off-Label Use ofAlemtuzumab, Belatacept, and Rapamycin in Kidney Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION. 2024. p. S492–S492.
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
June 2024
Volume
24
Issue
6
Start / End Page
S492 / S492
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences